Stanley Laman Group, Ltd. Johnson & Johnson Transaction History

Stanley Laman Group, Ltd.

$636 Million
Q2 2024

A detailed history of Stanley Laman Group, Ltd. transactions in Johnson & Johnson stock. As of the latest transaction made, Stanley Laman Group, Ltd. holds 1,733 shares of JNJ stock, worth $285,633. This represents 0.04% of its overall portfolio holdings.

Number of Shares

1,733

Previous 1,733 -0.0%

Holding current value

$285,633

Previous $274,000 7.66%

% of portfolio

0.04%

Previous 0.04%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 02, 2024	SELL	$145.6 - $158.88 $25,188 - $27,486	-173 Reduced 9.08%	1,733 $271,000
Q3 2023 Oct 16, 2023	SELL	$155.75 - $174.48 $623 - $697	-4 Reduced 0.21%	1,906 $296,000
Q2 2023 Aug 08, 2023	BUY	$154.35 - $166.11 $6,637 - $7,142	43 Added 2.3%	1,910 $316,000
Q1 2023 Apr 17, 2023	BUY	$151.05 - $180.26 $282,010 - $336,545	1,867 New	1,867 $289,000
Q2 2022 Aug 08, 2022	BUY	$168.19 - $186.01 $209,228 - $231,396	1,244 New	1,244 $221,000
Q3 2021 Nov 03, 2021	SELL	$161.5 - $179.47 $2.69 Million - $2.99 Million	-16,644 Closed	0 $0
Q2 2021 Jul 28, 2021	BUY	$159.48 - $171.07 $246,556 - $264,474	1,546 Added 10.24%	16,644 $2.74 Million
Q1 2021 May 05, 2021	BUY	$153.07 - $170.48 $104,240 - $116,096	681 Added 4.72%	15,098 $2.48 Million
Q4 2020 Feb 09, 2021	BUY	$137.11 - $157.38 $167,822 - $192,633	1,224 Added 9.28%	14,417 $2.27 Million
Q3 2020 Oct 20, 2020	BUY	$140.38 - $153.83 $12,914 - $14,152	92 Added 0.7%	13,193 $1.96 Million
Q2 2020 Jul 20, 2020	BUY	$128.81 - $155.51 $760,880 - $918,597	5,907 Added 82.11%	13,101 $1.84 Million
Q1 2020 May 12, 2020	BUY	$111.14 - $153.99 $68,239 - $94,549	614 Added 9.33%	7,194 $943,000
Q4 2019 Feb 04, 2020	SELL	$127.5 - $146.44 $87,465 - $100,457	-686 Reduced 9.44%	6,580 $960,000
Q3 2019 Nov 08, 2019	SELL	$126.95 - $142.14 $132,662 - $148,536	-1,045 Reduced 12.57%	7,266 $940,000
Q2 2019 Aug 01, 2019	BUY	$131.15 - $144.24 $28,984 - $31,877	221 Added 2.73%	8,311 $1.16 Million
Q1 2019 May 10, 2019	BUY	$125.72 - $139.79 $25,772 - $28,656	205 Added 2.6%	8,090 $1.13 Million
Q4 2018 Feb 07, 2019	BUY	$122.84 - $147.84 $368 - $443	3 Added 0.04%	7,885 $1.02 Million
Q3 2018 Oct 30, 2018	SELL	$121.58 - $142.88 $27,963 - $32,862	-230 Reduced 2.84%	7,882 $1.09 Million
Q2 2018 Aug 09, 2018	BUY	$119.4 - $131.76 $60,058 - $66,275	503 Added 6.61%	8,112 $984,000
Q1 2018 May 01, 2018	SELL	$125.1 - $148.14 $23,894 - $28,294	-191 Reduced 2.45%	7,609 $975,000
Q4 2017 Feb 09, 2018	SELL	$131.22 - $143.62 $26,637 - $29,154	-203 Reduced 2.54%	7,800 $1.09 Million
Q3 2017 Nov 13, 2017	BUY	$129.47 - $135.38 $1.04 Million - $1.08 Million	8,003	8,003 $1.04 Million

Others Institutions Holding JNJ

# of Institutions

4,161

Shares Held

1.69B

Call Options Held

12.5M

Put Options Held

10.3M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $431B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stanley Laman Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Stanley Laman Group, Ltd. with notifications on news.

Account

Stanley Laman Group, Ltd. Johnson & Johnson Transaction History